PMV Pharmaceuticals, Inc.
PMV Pharmaceuticals, Inc. scores highest on Torque (60) and lowest on Price (36). Its PosiPenta is 46.30 out of 100, around the middle of similar companies.
On the Penta Grid this week, PMV Pharmaceuticals, Inc. is Grid #359 of 837 in the Healthcare sector in United States, and Grid #2,292 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| PMV Pharmaceuticals, Inc. | 46.30 | 36 | 42 | 57 | 60 | 37 |
| Immunic, Inc. | 39.67 | 43 | 33 | 40 | 51 | 33 |
| Vivani Medical, Inc. | 34.40 | 13 | 45 | 53 | 16 | 45 |
| Coya Therapeutics, Inc. | 45.28 | 26 | 28 | 49 | 65 | 58 |
| Stereotaxis, Inc. | 32.77 | 12 | 58 | 19 | 27 | 48 |
| Polaryx Therapeutics, Inc. | 40.50 | 8 | 72 | 4 | 59 | 60 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -0.85 |
| P/B ratio | 1.28 |
EEarnings
| Trailing EPS | ₹-134.50 |
| Forward EPS | ₹-91.56 |
NNitro
| Price | 114.61 |
| 52-week high | 180.91 |
| 52-week low | 96.61 |
| Fall from 52-week high | 36.6% |
TTorque
| Return on equity (ROE) | -70.93% |
| Debt-to-equity | 0.00 |
AAnchor
| Beta (price swings) | 1.35 |
| Market cap | ₹865 Cr |
| Insider holding | 2.37% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is PMV Pharmaceuticals, Inc.'s PosiPenta score?
PMV Pharmaceuticals, Inc.'s PosiPenta is 46.30 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does PMV Pharmaceuticals, Inc. stand on the Penta Grid?
On the Penta Grid this week, PMV Pharmaceuticals, Inc. is Grid #359 of 837 in the Healthcare sector in United States, and Grid #2,292 of 4,000 in United States.
Which PosiPenta pillar is strongest for PMV Pharmaceuticals, Inc.?
Torque (durability), with a score of 60 out of 100: around the middle of similar companies.
Which PosiPenta pillar is weakest for PMV Pharmaceuticals, Inc.?
Price (valuation), with a score of 36 out of 100: weaker than most similar companies.
Has PMV Pharmaceuticals, Inc.'s PosiPenta changed since last week?
Yes, it rose 3.07 points, from 43.23 to 46.30.
PositoAI is for research and education only and is not investment advice.